Population
Platelets (including FcRgamma chain-deficient, CD36-deficient, and human platelets)
Design
Preclinical
Authors
Loading...
GPVI/FcRγ remains a viable antithrombotic target; confirms complex dependence across collagens but should not yet change practice.
This preclinical study confirms the critical role of the GPVI/FcRgamma chain complex in platelet activation by various collagens, with alpha2beta1 integrin playing a modulatory role.
Jarvis et al. (2002) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: